CDK12-altered prostate cancer: Clinical features and therapeutic outcomes to standard systemic therapies, PARP inhibitors, and PD1 inhibitors

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; pp. v326 - v327
Main Authors Antonarakis, E.S., Velho, P Isaacsson, Agarwal, N., Santos, V Sacristan, Maughan, B.L., Pili, R., Adra, N., Sternberg, C.N., Vlachostergios, P.J., Tagawa, S.T., Bryce, A.H., McNatty, A.L., Reichert, Z.R., Dreicer, R., Sartor, O., Lotan, T.L., Hussain, M.
Format Journal Article
LanguageEnglish
Published 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdz248.002